Pathogen-Associated Molecular Pattern (PAMP)

Pathogen-Associated Molecular Pattern (PAMP) designates conserved molecular structures present in microbes but absent in host cells, recognised by innate immune receptors as danger signals triggering rapid immune activation against infection. Common PAMPs include lipopolysaccharide from Gram-negative bacteria, peptidoglycan from bacterial cell walls, flagellin from bacterial flagella, unmethylated CpG DNA motifs, and viral double-stranded RNA.

The biopharmaceutical industry applies PAMP biology extensively in vaccine development, immunotherapy, and infectious disease research, as PAMP recognition initiates cytokine release, dendritic cell activation, and adaptive immune priming essential for protective immunity. Pattern recognition receptors such as Toll-like receptors, NOD-like receptors, and RIG-I-like receptors detect PAMPs and trigger signalling cascades activating NF-kB and interferon pathways. Vaccine adjuvants often exploit PAMP-like molecules to enhance immunogenicity, improving antibody and T-cell responses to weak antigens. Therapeutic strategies also target PAMP signalling to reduce excessive inflammation in sepsis, autoimmune conditions, or chronic inflammatory diseases. Understanding PAMP recognition enables rational design of immunomodulatory therapies, safer vaccine adjuvants, and novel antimicrobial approaches, making this concept foundational for translating innate immunity into therapeutic innovation.